Enveric Biosciences Reports Q2 2026 Financial Results

What Happened Enveric Biosciences, Inc. (ENVB) announced a corporate update and reported its financial results for the second quarter ended June 30, 2026 in a press release dated August 14, 2026. The company furnished the press release as Exhibit 99.1 to a Form 8-K filed on August 14, 2026.

Key Details

• Press release/photo: Dated August 14, 2026 and furnished as Exhibit 99.1 to the Form 8-K.
• Reporting period: Financial results cover the quarter ended June 30, 2026.
• Form 8-K items: Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Exhibits) are reported.
• Disclosure status: The press release was furnished as an exhibit to the 8-K (information furnished in the filing).

Why It Matters This filing provides Enveric’s latest quarterly financial results and a corporate update—key facts investors use to assess revenue, profitability, cash position, and near-term business progress. Retail investors should read the furnished press release (Exhibit 99.1) for the specific financial figures and any operational or strategic commentary that could influence investment decisions.